Next Article in Journal
Personalized Combination Therapy in Bladder Cancer: cAMP Modulators Synergize with 5-FU and Modulate Redox Programs
Next Article in Special Issue
Prognostic Analysis of Endoprosthetic Reconstruction Versus Biological Reconstruction in the Treatment of Extremity Osteosarcoma
Previous Article in Journal
PARP Inhibitors Combined with Abiraterone Overcome Resistance in Metastatic Castration-Resistant Prostate Cancer Independently of Androgen Receptor
Previous Article in Special Issue
Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of Cancer
 
 
Review

Article Versions Notes

Cancers 2026, 18(4), 561; https://doi.org/10.3390/cancers18040561
Action Date Notes Link
article html file updated 2 September 2026 23:51 CEST Update https://www.mdpi.com/2072-6694/18/4/561/html
article html file updated 9 February 2026 19:31 CET Update -
article html file updated 9 February 2026 10:44 CET Original file -
article pdf uploaded. 9 February 2026 10:42 CET Version of Record https://www.mdpi.com/2072-6694/18/4/561/pdf
article xml uploaded. 9 February 2026 10:42 CET Update https://www.mdpi.com/2072-6694/18/4/561/xml
article xml file uploaded 9 February 2026 10:42 CET Original file -
Back to TopTop